Thorne HealthTech, Inc. (“Thorne HealthTech” or “Thorne”) (NASDAQ:THRN), a leader in developing innovative solutions for a personalized approach to health and well-being, today relaunched its Gut Health Test with the inclusion of its patent-pending Microbiome Wipe, a first-to-market approach to microbiome testing. Thorne’s Microbiome Wipe revolutionizes the user experience of microbiome testing by eliminating inconvenient stool sampling that often leads users to either postpone the test or not take it at all.
RBC Capital Maintains Sector Perform on Mosaic, Lowers Price Target to $60
RBC Capital analyst Andrew Wong maintains Mosaic (NYSE:MOS) with a Sector Perform and lowers the price target from $65 to $60.
